Ocular Therapeutix Expands Stock Incentive Plan for Employees
PremiumCompany AnnouncementsOcular Therapeutix Expands Stock Incentive Plan for Employees
24d ago
JMP Securities healthcare analysts hold an analyst/industry conference call
Premium
The Fly
JMP Securities healthcare analysts hold an analyst/industry conference call
2M ago
Ocular Therapeutix Appoints Donald Notman as COO
Premium
Company Announcements
Ocular Therapeutix Appoints Donald Notman as COO
2M ago
Ocular Therapeutix reports Q2 EPS (26c), consensus (22c)
PremiumThe FlyOcular Therapeutix reports Q2 EPS (26c), consensus (22c)
3M ago
OCUL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
OCUL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Ocular Therapeutix announces first patients enrolled in Phase 3 SOL-R study
Premium
The Fly
Ocular Therapeutix announces first patients enrolled in Phase 3 SOL-R study
3M ago
Ocular provided positive update on enrollment, says Piper Sandler
PremiumThe FlyOcular provided positive update on enrollment, says Piper Sandler
5M ago
Ocular Therapeutix Shareholders Approve Expansion and Leadership Changes
Premium
Company Announcements
Ocular Therapeutix Shareholders Approve Expansion and Leadership Changes
5M ago
Ocular Therapeutix: Progress made with AXPAXLI SOL-1 for wet AMD
Premium
The Fly
Ocular Therapeutix: Progress made with AXPAXLI SOL-1 for wet AMD
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100